Applied Therapeutics, Inc. Comprehensive Income
Applied Therapeutics, Inc. reported Comprehensive Income of -$105.62 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-04-15
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was $44.01M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was -$68.59M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was $2.90M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$83.94M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$105.62M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$119.81M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$82.35M.
- Applied Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$105.58M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-12-31 | $44.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$24.58M derived: sum of 2 quarters · filed 2025-04-15 | -$21.69M derived: sum of 3 quarters · filed 2025-04-15 | -$105.62M 10-K · filed 2025-04-15 |
| 2024-09-30 | -$68.59M 10-Q · filed 2024-11-07 | -$65.69M derived: sum of 2 quarters · filed 2024-11-07 | -$149.63M 10-Q · filed 2024-11-07 | -$187.31M derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-06-30 | $2.90M 10-Q · filed 2024-08-07 | -$81.04M 10-Q · filed 2024-08-07 | -$118.72M derived: sum of 3 quarters · filed 2025-04-15 | -$161.09M derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-03-31 | -$83.94M 10-Q · filed 2024-05-09 | -$121.62M derived: sum of 2 quarters · filed 2025-04-15 | -$163.99M derived: sum of 3 quarters · filed 2025-04-15 | -$193.56M derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | -$37.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$80.05M derived: sum of 2 quarters · filed 2025-04-15 | -$109.63M derived: sum of 3 quarters · filed 2025-04-15 | -$119.81M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$42.37M 10-Q · filed 2024-11-07 | -$71.95M derived: sum of 2 quarters · filed 2024-11-07 | -$82.14M 10-Q · filed 2024-11-07 | -$96.54M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$29.58M 10-Q · filed 2024-08-07 | -$39.77M 10-Q · filed 2024-08-07 | -$54.17M derived: sum of 3 quarters · filed 2024-08-07 | -$73.25M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$10.19M 10-Q · filed 2024-05-09 | -$24.59M derived: sum of 2 quarters · filed 2024-05-09 | -$43.67M derived: sum of 3 quarters · filed 2024-05-09 | -$69.44M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$14.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$33.48M derived: sum of 2 quarters · filed 2024-03-06 | -$59.26M derived: sum of 3 quarters · filed 2024-03-06 | -$82.35M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$19.08M 10-Q · filed 2023-11-09 | -$44.85M derived: sum of 2 quarters · filed 2023-11-09 | -$67.95M 10-Q · filed 2023-11-09 | -$94.96M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$25.77M 10-Q · filed 2023-08-10 | -$48.87M 10-Q · filed 2023-08-10 | -$75.88M derived: sum of 3 quarters · filed 2023-08-10 | -$104.36M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$23.09M 10-Q · filed 2023-05-11 | -$50.11M derived: sum of 2 quarters · filed 2023-05-11 | -$78.59M derived: sum of 3 quarters · filed 2023-05-11 | -$104.45M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$27.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$55.50M derived: sum of 2 quarters · filed 2023-03-23 | -$81.36M derived: sum of 3 quarters · filed 2023-03-23 | -$105.58M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$28.49M 10-Q · filed 2022-11-09 | -$54.35M derived: sum of 2 quarters · filed 2022-11-09 | -$78.57M 10-Q · filed 2022-11-09 | -$102.27M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$25.86M 10-Q · filed 2022-08-12 | -$50.08M 10-Q · filed 2022-08-12 | -$73.79M derived: sum of 3 quarters · filed 2022-08-12 | -$103.70M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$24.22M 10-Q · filed 2022-05-12 | -$47.93M derived: sum of 2 quarters · filed 2022-05-12 | -$77.84M derived: sum of 3 quarters · filed 2022-05-12 | -$106.01M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$23.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$53.62M derived: sum of 2 quarters · filed 2022-03-10 | -$81.79M derived: sum of 3 quarters · filed 2022-03-10 | -$94.07M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$29.91M 10-Q · filed 2021-11-12 | -$58.09M derived: sum of 2 quarters · filed 2021-11-12 | -$70.36M 10-Q · filed 2021-11-12 | -$88.01M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$28.18M 10-Q · filed 2021-08-12 | -$40.45M 10-Q · filed 2021-08-12 | -$58.10M derived: sum of 3 quarters · filed 2021-08-12 | -$68.80M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$12.28M 10-Q · filed 2021-05-11 | -$29.92M derived: sum of 2 quarters · filed 2021-05-11 | -$40.63M derived: sum of 3 quarters · filed 2021-05-11 | -$49.06M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$17.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$28.35M derived: sum of 2 quarters · filed 2021-03-18 | -$36.78M derived: sum of 3 quarters · filed 2021-03-18 | -$45.52M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$10.70M 10-Q · filed 2020-11-12 | -$19.14M derived: sum of 2 quarters · filed 2020-11-12 | -$27.87M 10-Q · filed 2020-11-12 | -$34.59M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$8.44M 10-Q · filed 2020-08-11 | -$17.17M 10-Q · filed 2020-08-11 | -$23.89M derived: sum of 3 quarters · filed 2020-08-11 | -$28.17M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | -$8.73M 10-Q · filed 2020-05-11 | -$15.45M derived: sum of 2 quarters · filed 2020-05-11 | -$19.73M derived: sum of 3 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$11.00M derived: sum of 2 quarters · filed 2020-03-13 | -$16.52M 10-K · filed 2020-03-13 | |
| 2018-09-30 | -$4.28M 10-Q · filed 2019-11-13 | -$9.80M 10-Q · filed 2019-11-13 |